Skip to main content

Advertisement

Log in

Juvenile Idiopathic Arthritis

  • Review Article
  • Published:
Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The International League of Associations for Rheumatology (ILAR) has defined JIA as “arthritis of unknown etiology persisting for ≥6 wk with an onset at <16 y of age, after excluding other causes of joint inflammation”. Synovial inflammation is the result of a complex interplay of aberrant immune systems (both adaptive and innate) in a genetically susceptible individual, with possible external stimuli/triggers. Diagnosis of JIA essentially remains clinical, and laboratory investigations usually help to assess the severity of disease activity. Few investigations like antinuclear antibodies (ANA), human leukocyte antigen (HLA)-B27, and rheumatoid factor (RF) help to categorize or prognosticate a child with JIA. Timely use of effective therapeutic interventions including biological has shown good long-term outcomes of JIA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377:2138–49.

    Article  PubMed  Google Scholar 

  2. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.

    PubMed  Google Scholar 

  3. Petty RE, Laxer RM, Wedderburn LR. Juvenile idiopathic arthritis: classification and basic concepts. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC, eds. Textbook of Paediatric Rheumatology, 8th ed. Philadelphia: Elsevier; 2021. p. 211–2.

  4. Consolaro A, Giancane G, Alongi A, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health. 2019;3:255–63.

    Article  PubMed  Google Scholar 

  5. Seth V, Kabra SK, Semwal OP, et al. Clinico-immunological profile in juvenile rheumatoid arthritis–an Indian experience. Indian J Pediatr. 1996;63:293–300.

    Article  CAS  PubMed  Google Scholar 

  6. Chandrasekaran AN, Rajendran CP, Madhavan R. Juvenile rheumatoid arthritis–Madras experience. Indian J Pediatr. 1996;63:501–10.

    Article  CAS  PubMed  Google Scholar 

  7. Ravichandran R, Vasanthy N, Rajendran CP, et al. Clinical and articular presentation of juvenile idiopathic arthritis. Pediatr Rheumatol. 2008;6:P78.

    Article  Google Scholar 

  8. Nandi M, Ganguli SK, Mondal R, et al. Clinico-serological profile of juvenile idiopathic arthritis. Indian Pediatr. 2009;46:640–1.

    PubMed  Google Scholar 

  9. Kunjir V, Venugopalan A, Chopra A. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study. J Rheumatol. 2010;37:1756–62.

    Article  PubMed  Google Scholar 

  10. Mondal R, Sarkar S, Das NK, et al. Growth of children with juvenile idiopathic arthritis. Indian Pediatr. 2014;51:199–202.

    Article  PubMed  Google Scholar 

  11. Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J. 2021;19:135.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ringold S, Horneff G. Oligoarticular juvenile idiopathic arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC, editors. Textbook of Paediatric Rheumatology. 8th ed. Philadelphia: Elsevier; 2021. p. 243–7.

    Google Scholar 

  13. Rosenberg AM, Jariwala M, Cron RQ. Polyarticular juvenile idiopathic arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC, editors. Textbook of Paediatric Rheumatology. 8th ed. Philadelphia: Elsevier; 2021. p. 228–30.

    Google Scholar 

  14. Kimura Y, Vastert SJ. Systemic juvenile idiopathic arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC, editors. Textbook of Paediatric Rheumatology. 8th ed. Philadelphia: Elsevier; 2021. p. 216–22.

    Google Scholar 

  15. Tse SML, Colbert RA. Enthesitis-related arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC, editors. Textbook of Paediatric Rheumatology. 8th ed. Philadelphia: Elsevier; 2021. p. 252–3.

    Google Scholar 

  16. Nigrovic PA, Stoll ML. Psoriatic juvenile idiopathic arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC, editors. Textbook of Paediatric Rheumatology. 8th ed. Philadelphia: Elsevier; 2021. p. 271–7.

    Google Scholar 

  17. Gibbs JE, Ray DW. The role of the circadian clock in rheumatoid arthritis. Arthritis Res Ther. 2013;15:205.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Orange DE, Blachere NE, DiCarlo EF, et al. Rheumatoid arthritis morning stiffness is associated with synovial fibrin and neutrophils. Arthritis Rheumatol. 2020;72:557–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Sen ES, Ramanan AV, Rosenbaum JT. Uveilitis in juvenile idiopathic arthritis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC, editors. Textbook of Paediatric Rheumatology. 8th ed. Philadelphia: Elsevier; 2021. p. 280.

    Google Scholar 

  20. Angeles-Han ST, Ringold S, Beukelman T, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken). 2019;71:703–16.

    Article  PubMed  Google Scholar 

  21. Martini A, Lovell DJ, Albani S, et al. Juvenile idiopathic arthritis. Nat Rev Dis Primers. 2022;8:5.

    Article  PubMed  Google Scholar 

  22. Woo P. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome. Nat Clin Pract Rheumatol. 2006;2:28–34.

    Article  PubMed  Google Scholar 

  23. Martini A. Systemic juvenile idiopathic arthritis. Autoimmun Rev. 2012;12:56–9.

    Article  CAS  PubMed  Google Scholar 

  24. Martini A, Ravelli A, Avcin T, et al. Toward new classification criteria for juvenile idiopathic arthritis: first steps, Pediatric Rheumatology International Trials Organization International Consensus. J Rheumatol. 2019;46:190–7.

    Article  PubMed  Google Scholar 

  25. Kumar S. Systemic juvenile idiopathic arthritis: diagnosis and management. Indian J Pediatr. 2016;83:322–7.

    Article  PubMed  Google Scholar 

  26. Hahn Y-S. Enthesitis-related arthritis J Rheum Dis. 2018;25:221–30.

    Google Scholar 

  27. Weiss PF. Diagnosis and treatment of enthesitis-related arthritis. Adolesc Health Med Ther. 2012;2012:67–74.

    PubMed  Google Scholar 

  28. Jarlborg M, Gabay C. Systemic effects of IL-6 blockade in rheumatoid arthritis beyond the joints. Cytokine. 2022;149:155742.

    Article  CAS  PubMed  Google Scholar 

  29. Guzmán J, Burgos-Vargas R, Duarte-Salazar C, et al. Reliability of the articular examination in children with juvenile rheumatoid arthritis: interobserver agreement and sources of disagreement. J Rheumatol. 1995;22:2331–6.

    PubMed  Google Scholar 

  30. Miller E, Uleryk E, Doria AS. Evidence-based outcomes of studies addressing diagnostic accuracy of MRI of juvenile idiopathic arthritis. Am J Roentgenol. 2009;192:1209–18.

    Article  Google Scholar 

  31. Sudhakar M, Deswal S, Sachdev N, et al. The reliability of Juvenile Arthritis Magnetic Resonance Imaging Scoring system in the evaluation of the shoulder joint in juvenile idiopathic arthritis. Arch Rheumatol. 2022;37:547–58.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Brijendra P, Sudhakar M, Pal S, et al. Magnetic resonance imaging findings in the sternoclavicular joint in juvenile idiopathic arthritis and comparison with clinical examination. Clin Rheumatol. 2021;40:2351–9.

    Article  PubMed  Google Scholar 

  33. Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA. 2005;294:1671–84.

    Article  CAS  PubMed  Google Scholar 

  34. Onel KB, Horton DB, Lovell DJ, et al. 2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: recommendations for nonpharmacologic therapies, medication monitoring, immunizations, and imaging. Arthritis Care Res (Hoboken). 2022;74:505–20.

    Article  PubMed  Google Scholar 

  35. Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63:465–82.

    Article  PubMed  Google Scholar 

  36. Giannini EH, Cawkwell GD. Drug treatment in children with juvenile rheumatoid arthritis. Past, present, and future. Pediatr Clin North Am. 1995;42:1099–125.

    Article  CAS  PubMed  Google Scholar 

  37. Lovell DJ, Giannini EH, Brewer EJ Jr. Time course of response to nonsteroidal anti inflammatory drugs in juvenile rheumatoid arthritis. Arthritis Rheum. 1984;27:1433–7.

    Article  CAS  PubMed  Google Scholar 

  38. Ringold S, Angeles-Han ST, Beukelman T, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis. Arthritis Care Res (Hoboken). 2019;71:717–34.

    Article  PubMed  Google Scholar 

  39. Silverman E, Spiegel L, Hawkins D, et al. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2005;52:554–62.

    Article  CAS  PubMed  Google Scholar 

  40. O’Dell JR, Mikuls TR, Taylor TH, et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. 2013;369:307–18.

    Article  CAS  PubMed  Google Scholar 

  41. Ruperto N, Brunner HI, Synoverska O, et al. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. Lancet. 2021;398:1984–96.

    Article  CAS  PubMed  Google Scholar 

  42. Ringold S, Weiss PF, Beukelman T, et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum. 2013;65:2499–512.

    Article  PubMed  PubMed Central  Google Scholar 

  43. García-Carrasco M, Fuentes-Alexandro S, Escárcega RO, Rojas-Rodriguez J, Escobar LE. Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis. Joint Bone Spine. 2007;74:500–3.

    Article  PubMed  Google Scholar 

  44. Silverman ED, Cawkwell GD, Lovell DJ, et al. Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol. 1994;21:2353–8.

    CAS  PubMed  Google Scholar 

  45. Consolaro A, Giancane G, Schiappapietra B, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14:23.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

MS wrote this review. SK finalised the manuscript. SK will act as the guarantor for this manuscript. 

Corresponding author

Correspondence to Sathish Kumar.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sudhakar, M., Kumar, S. Juvenile Idiopathic Arthritis. Indian J Pediatr (2024). https://doi.org/10.1007/s12098-023-04939-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12098-023-04939-5

Keywords

Navigation